CIBCX
Price
$82.55
Change
-$0.06 (-0.07%)
Updated
Jun 15 closing price
Net Assets
127.98B
GBLCX
Price
$42.51
Change
+$0.39 (+0.93%)
Updated
Jun 15 closing price
Net Assets
33.24B
Interact to see
Advertisement

CIBCX vs GBLCX

Header iconCIBCX vs GBLCX Comparison
Open Charts CIBCX vs GBLCXBanner chart's image
CIBCX vs GBLCX Comparison Chart in %
View a ticker or compare two or three
VS
CIBCX vs. GBLCX commentary
Jun 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIBCX is a Buy and GBLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIBCX has more cash in the bank: 128B vs. GBLCX (33.2B). CIBCX pays higher dividends than GBLCX: CIBCX (2.02) vs GBLCX (1.48). CIBCX was incepted earlier than GBLCX: CIBCX (25 years) vs GBLCX (15 years). GBLCX (1.55) is less costly to investors than CIBCX (1.33). CIBCX (50.00) and GBLCX (50.00) have comparable annual turnover. CIBCX (250) and GBLCX (250) have matching initial minimum investment requirements. CIBCX annual gain was more profitable for investors over the last year : 11.73 vs. GBLCX (10.70). CIBCX return over 5 years is better than : 32.73 vs. GBLCX (13.24).
CIBCXGBLCXCIBCX / GBLCX
Total Expense Ratio1.331.5586%
Annual Report Gross Expense Ratio1.331.5586%
Fund Existence25 years15 years-
Gain YTD7.7405.883132%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets128B33.2B386%
Annual Yield % from dividends2.021.48137%
Returns for 1 year11.7310.70110%
Returns for 3 years36.9726.90137%
Returns for 5 years32.7313.24247%
Returns for 10 years64.1953.29120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMCFX14.790.09
+0.61%
Royce Micro-Cap Svc
FEMSX31.51N/A
N/A
Fidelity Series Emerging Markets Opps
GSTKX23.79N/A
N/A
Goldman Sachs International Eq Inc Inv
CPOAX43.91N/A
N/A
Morgan Stanley Insight A
PZVMX13.41N/A
N/A
Pzena Mid Cap Value Investor